IP Verse

Glaxosmithkline vs. Moderna - UPC_CFI_0002033/2025

The case UPC_CFI_0002033/2025 was filed by the plaintiff Glaxosmithkline Biologicals against the defendant Moderna on 04 Jul, 2025.

Case Timeline

04 Jul, 2025
Case Filed
12 Jan, 2026
Counterclaim for Revocation
13 Jan, 2026
Written Procedure
Today Jun 6, 2026
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_0002033/2025

    Patent Number:

    EP4066856

    Filing Date:

    04 Jul, 2025

    Proceeding Type:

    Counter Claim For Revocation

    Case Phase:

    Written Phase

    Plaintiffs:

    • Glaxosmithkline Biologicals

    Plaintiff Representative:

    • Tjibbe Douma

    Defendants:

    • Moderna
    • Moderna Belgium
    • Moderna Biotech Distributor UK
    • Moderna Biotech Spain
    • Moderna Biotech UK
    • Moderna France Sasu
    • Moderna Germany
    • Moderna Italy
    • Moderna Netherlands
    • Moderna Norway
    • Moderna Poland SP ZOO
    • Moderna Portugal Unipessoal LDA
    • Moderna Sweden
    • Moderna Switzerland
    • Modernatx

    Defendant Representative:

    • Gertjan Kuipers
    • Thomas WOLTER

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Martin Schmidt
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Jun 4, 2026
DateTitle

Notify me when new UPC document is filed

May 20, 2026Statement Of Rejoinder
May 20, 2026Receipt
May 20, 2026Exhibit Defendant
May 20, 2026Cover Sheet
Apr 27, 2026Receipt
Apr 27, 2026Document
Apr 27, 2026Cover Sheet
Apr 23, 2026Receipt
Apr 23, 2026Cover Sheet
Apr 23, 2026Application Document Claimant
Apr 20, 2026Receipt
Apr 20, 2026Exhibit Defendant
Apr 20, 2026Exhibit Claimant
Apr 20, 2026Cover Sheet
Apr 20, 2026Counterclaim Rejoinder
Apr 20, 2026Application Document Claimant
Apr 20, 2026Action.Communication
Apr 1, 2026Action.Publishorderdecision
Mar 19, 2026Receipt
Mar 19, 2026Exhibit Claimant
Mar 19, 2026Cover Sheet
Mar 19, 2026Counterclaim Reply
Mar 19, 2026Application To Amend Patent Defence
Mar 5, 2026Order
Mar 5, 2026Action.Issueorder
Mar 3, 2026Receipt
Mar 3, 2026Document Claimant
Mar 3, 2026Cover Sheet
Feb 24, 2026Order
Feb 24, 2026Action.Issueorder
Jan 21, 2026Receipt
Jan 21, 2026Other Document Claimant
Jan 21, 2026Cover Sheet
Jan 13, 2026Receipt
Jan 13, 2026Other Document Defendant
Jan 13, 2026Cover Sheet
Jan 13, 2026Application Document Defendant
Jan 12, 2026Receipt
Jan 12, 2026Exhibit Document Defendant
Jan 12, 2026Cover Sheet
Jan 12, 2026Counterclaim Defence With Amend Patent
Jan 12, 2026Application Document Defendant
Dec 22, 2025Receipt
Dec 22, 2025Further Pleadings
Dec 22, 2025Cover Sheet

More cases involving EP4066856B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jun 4, 2026
Case NumberFiling DatePlaintiffsDefendants
ACT_32173/2025Jul 4, 2025GlaxosmithklineModerna
UPC_CFI_619/2025Jul 4, 2025GlaxosmithklineModerna
ACT_32285/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg, CP Pharmaceuticals CV, Pfizer

More cases involving Glaxosmithkline

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jun 4, 2026
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_0001439/2025Nov 6, 2025GlaxosmithklineModerna
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna
APP_33242/2025Jul 21, 2025Glaxosmithkline -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jun 4, 2026
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_0001407/2026Apr 24, 2026Curevac ManufacturingModerna, Moderna France, Moderna Poland SP Z OO
UPC_CFI_0001439/2025Nov 6, 2025GlaxosmithklineModerna
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna